B cell receptor specific for double-stranded DNA

The **B cell receptor specific for double-stranded DNA** is a membrane-bound immunoglobulin complex expressed on the surface of certain autoreactive B lymphocytes. This specialized form recognizes and binds to epitopes present on native double-stranded DNA molecules. The structure consists of paired heavy and light chains forming a Y-shaped molecule with variable regions that determine antigen specificity—here, conferring high affinity for dsDNA antigens[2]. Engagement with its cognate antigen can activate intracellular signaling cascades such as protein kinase C activation and MAPK pathway induction, ultimately influencing gene expression related to proliferation, differentiation, anergy, or apoptosis depending on signal strength and context[2][3]. These receptors are central to the pathogenesis of systemic lupus erythematosus (SLE), where their activation leads to production of pathogenic anti-dsDNA antibodies that contribute to tissue damage. Regulation occurs via mechanisms like clonal deletion or functional silencing; failures in these checkpoints allow survival/activation of autoreactive clones[1]. While no therapies currently target this specificity directly, it remains a key focus in understanding autoimmunity. In summary, this molecule is best classified as an **antigen-specific variant** within the broader family known as "B cell receptors," notable for its role in autoimmunity rather than as a conventional druggable target.

Other names

Anti-double-stranded DNA B cell receptorAnti-dsDNA BCRdsDNA-specific B cell receptor

No approved drugs act by directly modulating dsDNA-specific BCR; however, general mechanisms include inhibition of signaling pathways downstream from the receptor or depletion/modulation of autoreactive B cells.